MTD vs XERS · P/E 27, rev $1.97B vs rev $175.2M
Mettler-Toledo International Inc (MTD) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. XERS currently screens at market cap $760.7M.
Not investment advice. Open the MTD and XERS stock pages for the full models.
Not investment advice.